Combined Electromagnetic Field and a Plantar Resistance Exercise With Venous Leg Ulcer

Sponsor
Mona Mohamed Taha (Other)
Overall Status
Recruiting
CT.gov ID
NCT05410613
Collaborator
(none)
60
1
3
5
12.1

Study Details

Study Description

Brief Summary

The purpose of this study will investigate the effects of combined electromagnetic field and a plantar resistance exercise therapy versus electromagnetic field on healing of venous leg ulcer .

Condition or Disease Intervention/Treatment Phase
  • Combination Product: electromagnetic field and a plantar resistance exercise
  • Device: Pulsed electromagnetic field
  • Other: usual care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Combined Electromagnetic Field and a Plantar Resistance Exercise on Healing of Venous Leg Ulcer
Actual Study Start Date :
Jan 20, 2022
Anticipated Primary Completion Date :
Jun 15, 2022
Anticipated Study Completion Date :
Jun 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: combined electromagnetic field and a plantar resistance

Combination Product: electromagnetic field and a plantar resistance exercise
Pulsed electromagnetic field therapy applied with intensity equal to 3mt and frequency of magnetic field impulses equal to 4 Hz. a plantar resistance exercise therapy by the StepIt rocker pedal, the overall exercise program will be to exercise on the pedal with the index leg for 1 min - then rest it for 1min - and to repeat this 10 times (20 minutes). This regime will be done twice daily (e.g .morning and evening).

Experimental: electromagnetic field

Device: Pulsed electromagnetic field
Pulsed electromagnetic field therapy applied with intensity equal to 3mt and frequency of magnetic field impulses equal to 4 Hz

Active Comparator: conservative treatment for the ulcer

Other: usual care
standard general advice according to hospital protocol

Outcome Measures

Primary Outcome Measures

  1. Ulcer surface area [two months]

    Ulcer surface (UAS) would be calculated by placing a piece of sterilized transparency film over the ulcer and tracing the ulcer perimeter on the film with fine tipped transparency marker.

  2. Ulcer volume measurement [two months]

    Ulcer volume : The ulcer would be traced on transparent paper and placed over the metric graph paper to have the longest length and width. A disposable measuring tape would be directed into the deepest point of the ulcer to record the ulcer depth. (Width x length x depth) would be calculated to have the volume of the ulcer

  3. Pressure Ulcer Scale for Healing (PUSH) [two months]

    Categorize the ulcer with respect to surface area, exudate, and type of wound tissue

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

patients with venous leg ulcer

Exclusion Criteria:

patients who have one or more of the following conditions:

  • peripheral vascular disease (PVD), (ABPI<0.8).

  • venous leg ulcers with cellulitis or infection symptoms, as well as venous leg ulcers with necrotic tissue or slough or had more than one ulcer.

  • other types of ulcers, such as rheumatoid vasculitis, diabetic foot, and malignant ulceration; corticosteroids use ; patients with dementia or who were disoriented;

  • undertaken another physical therapy modality for ulcer healing.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Surgical department-Mansoura Health Insurance Hospital Mansoura Egypt

Sponsors and Collaborators

  • Mona Mohamed Taha

Investigators

  • Principal Investigator: ASMAA FAWZY EL-SAYED, lecturer, Surgical department-Mansoura Health Insurance Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mona Mohamed Taha, associate professor, Cairo University
ClinicalTrials.gov Identifier:
NCT05410613
Other Study ID Numbers:
  • P.T REC/012/003629
First Posted:
Jun 8, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022